Liquidia Announces Presentations at the 2022 American Thoracic Society (ATS) International ConferenceGlobeNewsWire • 05/16/22
Liquidia Corporation (LQDA) CEO Roger Jeffson Q12022 Results - Earnings Call TranscriptSeeking Alpha • 05/12/22
Liquidia Reports First Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/12/22
Liquidia Announces Oral Presentation at the 42nd Annual Meeting of International Society for Heart and Lung Transplant (ISHLT)GlobeNewsWire • 04/20/22
Liquidia Announces Closing of Public Offering of Common Stock and Full Exercise of Over-Allotment OptionGlobeNewsWire • 04/18/22
Liquidia Corporation's (LQDA) CEO Roger Jeffs on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/17/22
Liquidia Corporation Reports Full-Year 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/17/22
Is Liquidia Technologies, Inc. (LQDA) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 03/10/22
Liquidia Corporation to Report Full Year 2021 Financial Results on Thursday, March 17, 2022GlobeNewsWire • 03/10/22
Learning Lessons From 3 Stocks Flourishing In A Desperate Biotech Bear MarketSeeking Alpha • 03/08/22
Liquidia Re-Finances Debt Facility With Silicon Valley Bank To Increase To $40.0 MillionGlobeNewsWire • 01/07/22
Stipulation of Partial Judgment In Favor of Liquidia Filed In Hatch-Waxman LitigationGlobeNewsWire • 12/29/21
FDA Grants Tentative Approval for Liquidia's YUTREPIA™ (Treprostinil) Inhalation PowderGlobeNewsWire • 11/08/21
Liquidia Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/03/21